Ceribell (CBLL) Cash from Financing Activities (2023 - 2026)

Ceribell (CBLL) posted Cash from Financing Activities of $1.6 million for Q1 2026, up 16.32% on a QoQ basis from $1.4 million in Q4 2025, and up 81500.0% year-over-year from N/an in Q1 2025.

Ceribell (CBLL) Cash from Financing Activities (2023 - 2026) Analysis & Trends

Ceribell's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • Quarterly Cash from Financing Activities rose 81500.0% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 96.46% YoY) and the FY2025 annual result came in at $5.1 million, down 97.43% from the prior year.
  • Cash from Financing Activities was $1.6 million for Q1 2026 at Ceribell, up from $1.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $190.7 million in Q4 2024 and bottomed at -$3.5 million in Q4 2023.
  • A 4-year average of $20.0 million and a median of $1.5 million in 2025 frame the typical range for Cash from Financing Activities.
  • Peak annual rise in Cash from Financing Activities reached 100400.0% in 2025, while the deepest fall reached 99.97% in 2025.
  • Ceribell's Cash from Financing Activities stood at -$3.5 million in 2023, then soared by 5609.19% to $190.7 million in 2024, then slumped by 99.26% to $1.4 million in 2025, then grew by 16.32% to $1.6 million in 2026.
  • Business Quant data shows CBLL's Cash from Financing Activities at $1.6 million in Q1 2026, $1.4 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Ceribell 613.16 Mn 471.97 Mn 23.12 Mn 1.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.63 Mn
Mar 31, 2026 1.63 Mn
Dec 31, 2025 1.40 Mn
Dec 31, 2025 1.40 Mn
Sep 30, 2025 1.64 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 2.01 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 190.73 Mn
Dec 31, 2024 190.73 Mn
Sep 30, 2024 -1.89 Mn
Sep 30, 2024 -1.89 Mn
Jun 30, 2024 -2,000.00
Jun 30, 2024 -2,000.00
Mar 31, 2024 7.68 Mn
Mar 31, 2024 7.68 Mn
Dec 31, 2023 -3.46 Mn
Dec 31, 2023 -3.46 Mn